Aphria Inc. is a cannabis company founded in 2013-2014 in Canada, by Cole Cacciavillani and John Cervini. The company is listed on the New York Stock Exchange and the Toronto Stock Exchange and it has a market capitalization of around $1.2 billion, as of January 2020, that puts the company in the list of the largest cannabis companies in the world. Soon after the company secured medical license to grow and sell medical cannabis in its campus from the reputed organization Health Canada, it doubled the size of its greenhouse that aids in the cultivation of natural cannabis. In the first campus, Aphria produced around 110,000 kg of cannabis annually.
Another greenhouse is created by the company in the Leamington area, named Aphria Diamond, in collaboration with Double Diamond, the renowned greenhouse operator. The joint collaboration produced an additional 120,000 kg of cannabis. Besides this, the company also owns Broken Coast Cannabis Inc. which is licensed to produce 4,500 kg of cannabis annually.
Vision/Mission of Aphria
The mission of the company lies in reaching the pinnacle of success through a relentless commitment to society, thereby maintaining the integrity of the products through continuous innovation and product development. The company aims at providing global investors, with unlimited access to cannabis use all across the world.
How Aphria is different from other cannabis firms
Aphria reported total revenue of $126.1 million which is up by 800% as compared to what it was even a year ago. The company has also managed to secure over $90 million in revenue from Germany. This is an amazing development for a cannabis company and here are the reasons how the company is outperforming other Cannabis firms.
Perfect Business model
The company focusses more on sustainability with its exclusive greenhouse and cultivation procedures along with the extensive laboratories that make it one of the most integrated cannabis companies in the world.
Discounted price
Being in a more profitable position than most of its competitors, the cannabis products at Aphria, are priced at a significant discount.
German Subsidiary
It is of utmost importance for companies to secure support from not only their home countries but also on an international level. This is what Aphria managed to do, which spurt their revenues drastically. In fact, Aphria is one of the only 3 companies in Germany with a license that contributed heavily to their recent success.
Balanced approach
Investors dislike uncertainty; they only see the revenue count that their proposed company is earning. Aphria excels in earning mammoth revenues in a small-time which is what fascinated the investors. Many of the large-cap competitors of Aphria invested heavily in R&D, but few paid off immensely afterward. However, this worked in favor of Aphria, and therefore Aphria outperformed its competitors. Until and unless companies tame future investment by pleasing their current investors, they hardly excel in the cannabis industry.
Companies should keep a balanced approach to future growth and development and Aphria has perfected that in an efficient way. Aphria’s commitment towards society along with its innovative product quality is what drives the company to create a robust and healthy cannabis community across all its business venues. Utilizing the age-old greenhouse expertise and cannabis commercial agricultural practices, Aphria aims at growing medical cannabis plants under natural growing conditions, and till now, it has managed to be among the top cannabis-producing companies across the world. The initial few plants that the company grew, have grown into millions of healthy cannabis plants and earn accolades for the company to become one of the premier cannabis-producing companies across the world, with its presence felt in across 10 countries spread in 5 continents.